1. HMGB1 enhances the migratory and invasive abilities of A2780/DDP cells by facilitating epithelial to mesenchymal transition via GSK‑3β
   Jinhua Wang et al, 2024, Experimental and Therapeutic Medicine CrossRef
2. Clinical efficacy of plasmid encoding p62/SQSTM1 (Elenagen) in combination with gemcitabine in patients with platinum-resistant ovarian cancer: a randomized controlled trial
   Sergei Krasny et al, 2024, Frontiers in Oncology CrossRef